Novartis Venture Fund

Novartis Venture Fund (NVF) is a life-science venture fund that makes equity investments in biotechnology and biopharmaceutical companies across North America and Europe. NVF manages approximately USD 750 million, invests primarily at Seed and Series A stages (but may consider later-stage opportunities), typically invests USD 5–10 million per company with allocations up to USD 25 million, and takes an active, board-level role to support clinical and commercial development.

Industries

finance

therapeutics

venture-capital-b37d

Nr. of Employees

small (1-50)

Novartis Venture Fund

Basel, Basel-Stadt, Switzerland, Europe

https://nvfund.com

klydon@sosei.com

877 280 2296